Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cerulean Pharma Inc announces pricing of initial public offering


Thursday, 10 Apr 2014 11:09am EDT 

Cerulean Pharma Inc:Prices initial public offering of 8,500,000 shares of common stock at public offering price of $7 per share, before underwriting discounts.Grants underwriters 30-day option to purchase up to additional 1,275,000 shares of common stock at public offering price, less underwriting discounts.Common stock has been approved for listing on NASDAQ Global Market and is expected to begin trading under ticker symbol 'CERU.Offering is expected to close on April 15.Leerink Partners is acting as sole book-running manager for offering.Canaccord Genuity, JMP Securities and Wedbush PacGrow Life Sciences are acting as co-managers for offering. 

Company Quote

6.27
0.07 +1.13%
24 Apr 2015